Home » European Commission Approves Once-Weekly Etanercept for Psoriasis
European Commission Approves Once-Weekly Etanercept for Psoriasis
The European Commission has approved etanercept (Enbrel) 50 mg once-weekly dosage regimen as an alternative to the currently approved etanercept 25 mg twice-weekly regimen for the treatment of patients with moderate to severe plaque psoriasis.
Doctor’s Guide
Doctor’s Guide
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May